XVIVO hascarried out a directed share issue of 1,600,000 shares at a subscription priceof SEK 275 per share, raising gross proceeds of SEK 440 million.
The netproceeds are intended for increased investments in infrastructure andacceleration of the FDA PMA regulatory approval process in the US and toupscale the production of disposables to ensure delivery capacity and decreasedcosts for sold goods. Investors in the directed share issue include bothexisting and new shareholders.
Please readthe news in its entirety here.